Industry

Evry Health’s expansion furthered by company’s accreditation from the National Committee for Quality Assurance DALLAS–(BUSINESS WIRE)–#businesshealthinsurance—Evry Health, a tech-savvy employer health insurance company, announced today it has expanded its reliable, value-based health care to Austin, Houston and San Antonio. Launched earlier this year with a focus on the Dallas-Fort Worth (DFW) business-to-business market, Evry Health … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “U.S. Opioids Market, by Drugs, by Therapeutic Application, and by Distribution Channel – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. The increasing rate of unemployment is expected to drive the market growth, owing to the increased opioids misuse For instance, according to an article … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Statistical Elements of Implementing ICH Guidelines” training has been added to ResearchAndMarkets.com’s offering. This 2-day seminar explores the unique challenges facing quality functions of pharmaceutical and biotechnology companies. This seminar will provide attendees with an understanding of the fourteen ICH Quality guidelines as relates to statistical guidance and analysis. The course will provide … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Digital Pathology Market Research Report: Forecast (2022-27)” report has been added to ResearchAndMarkets.com’s offering. This report states that the market is expected to grow at a 14% CAGR during 2022-27. This research report provides comprehensive analysis on the growth, opportunities, challenges, trends, & outlook on the Global Digital Pathology Market Analysis, 2022 … [Read more…]

Innovative Virtual Reality and Behavioral Health Solution for Healing Trauma Continues to Expand LAS VEGAS–(BUSINESS WIRE)–Veteran workers’ compensation executive Chris Watson has joined Harvard MedTech as EVP and Chief Operating Officer. Harvard MedTech, a breakthrough digital health company, offers a revolutionary new approach to healing trauma and pain by combining virtual reality, artificial intelligence and … [Read more…]

FRISCO, Texas–(BUSINESS WIRE)–$ADUS–Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the second quarter ended June 30, 2022, on Monday, August 1, 2022, after the market close. Addus HomeCare will host a conference call on Tuesday, August 2, 2022, at 9:00 a.m. Eastern time. Joining … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Veterinary Pharmaceuticals Market Research Report by Product, Vaccines, Antibiotics, End User, Animal, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Veterinary Pharmaceuticals Market size was estimated at USD 28.91 billion in 2021 and expected to reach USD 32.95 billion in 2022, … [Read more…]

MCLEAN, Va.–(BUSINESS WIRE)–NTT DATA, a digital business and IT services leader was awarded a contract for government consulting and advisory by Hawaii’s Med-QUEST Division (MQD), the State of Hawaii Medicaid agency serving more than 430,900 Hawaii residents enrolled in Medicaid. The State of Hawaii, through the Department of Human Services (DHS), is building a Health … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Hidradenitis Suppurativa – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about 24+ companies and 24+ pipeline drugs in Hidradenitis Suppurativa pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, … [Read more…]

Fresenius Kabi Iodixanol Injection, USP is the first FDA-approved generic that is fully substitutable for Visipaque® LAKE ZURICH, Ill.–(BUSINESS WIRE)–#FreseniusKabi–Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the United States, starting immediately with the launch of Iodixanol Injection, USP, a product the U.S. Food and Drug Administration (FDA) … [Read more…]